Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Windtree Therapeutics (WINT)
NASDAQ:WINT
Holding WINT?
Track your performance easily
WINT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.21 - $14.75
Previous CloseN/A
Volume14.98M
Average Volume (3M)3.36M
Market Cap
$2.51M
Enterprise Value$12.94M
Total Cash (Recent Filing)$5.59M
Total Debt (Recent Filing)$25.00M
Price to Earnings (P/E)―
Beta1.61
Next Earnings
Apr 02, 2025EPS Estimate
-0.92Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-18.63
Shares Outstanding11,048,828
10 Day Avg. Volume6,217,928
30 Day Avg. Volume3,359,504
Standard Deviation2.28
R-Squared0.01
Alpha0.12
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)46.36
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market Cap5.16
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit294.16
Enterprise Value/Ebitda29.09
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
Windtree Therapeutics News
PremiumCompany Announcements
Windtree Therapeutics Strengthens Leadership Amid Strategic Shift
PremiumCompany Announcements
Windtree Therapeutics Reports Q3 2024 Financial ResultsOwnership Overview
0.24% Insiders
0.06% Mutual Funds
1.42% Other Institutional Investors
98.26% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
WINT FAQ
What was Windtree Therapeutics’s price range in the past 12 months?
Windtree Therapeutics lowest stock price was $0.21 and its highest was $14.75 in the past 12 months.
What is Windtree Therapeutics’s market cap?
Windtree Therapeutics’s market cap is $2.51M.
When is Windtree Therapeutics’s upcoming earnings report date?
Windtree Therapeutics’s upcoming earnings report date is Apr 02, 2025 which is in 70 days.
How were Windtree Therapeutics’s earnings last quarter?
Windtree Therapeutics released its earnings results on Nov 27, 2024. The company reported -$4.23 earnings per share for the quarter, missing the consensus estimate of -$2.27 by -$1.96.
Is Windtree Therapeutics overvalued?
According to Wall Street analysts Windtree Therapeutics’s price is currently Overvalued.
Does Windtree Therapeutics pay dividends?
Windtree Therapeutics does not currently pay dividends.
What is Windtree Therapeutics’s EPS estimate?
Windtree Therapeutics’s EPS estimate is -0.92.
How many shares outstanding does Windtree Therapeutics have?
Windtree Therapeutics has 11,048,828 shares outstanding.
What happened to Windtree Therapeutics’s price movement after its last earnings report?
Windtree Therapeutics reported an EPS of -$4.23 in its last earnings report, missing expectations of -$2.27. Following the earnings report the stock price went down -13.115%.
Which hedge fund is a major shareholder of Windtree Therapeutics?
Among the largest hedge funds holding Windtree Therapeutics’s share is Deerfield Management Company, LP. It holds Windtree Therapeutics’s shares valued at 0.
---
Company Description
Windtree Therapeutics
Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.
---
Technical Analysis
---